How Pharmacists Can Be Engaged in Myasthenia Gravis Care

Andrew J. Webb, PharmD, BCCCP is a neurocritical care clinical pharmacy specialist at Massachusetts General Hospital. He completed his undergraduate studies and Doctor of Pharmacy at the University of Rhode Island and then completed his PGY1 pharmacy residency at Mayo Clinic followed by a PGY2 in critical care at Oregon Health & Science University. He serves on several interprofessional institutional and professional organization committees, including the MGH Department of Neurology Quality and Patient Safety committee where has helped implement medication safety initiatives to ensure safe medication practices for patients with rare neurologic conditions including myasthenia gravis. Dr. Webb has also served as part of the Pharmacotherapy Specialty Recertification Literature Study and is an expert faculty member in Critical Care for ASHP.

Neelam Goyal, MD is a Clinical Professor of Neurology and Neurological Sciences in the division of Neuromuscular Medicine. She earned her medical degree at SUNY Downstate in Brooklyn, NY. Subsequently, she completed her neurology residency, which included a chief year, followed by a fellowship year in neurophysiology, specializing in neuromuscular disorders and EMG nerve conduction studies at Stanford University Medical Hospital. Dr. Goyal focuses on the diagnosis, management, and electrophysiological testing of neuromuscular disorders, including SFEMG. Her expertise extends to immune-mediated disorders such as myositis, myasthenia gravis, CIDP, and vasculitis. Her research interests involve monitoring and managing the short and long-term toxicity of immunosuppressive agents. She is actively involved in a grant-supported project investigating steroid toxicity in patients with myasthenia gravis.

Relevant Financial Relationship Disclosures

The following persons in control of this activity’s content have relevant financial relationships:

• Neelam Goyal: Principal Investigator – argenx, Advisor – argenx, Alexion, UCB, Janssen, Amgen, EMD Serono

All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity. 

RESOURCES

• Supporting Patients with Myasthenia Gravis: A Pharmacist’s Role in Individualizing Therapy and Improving Patient-Centered Outcomes

LISTEN ON